U.S. Intravenous Immunoglobulin Market to Surpass US$ 10.06 Billion by 2028, Says Coherent Market Insights (CMI)
14 janv. 2022 09h00 HE
|
CMI
SEATTLE, Jan. 14, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the U.S. intravenous immunoglobulin market is estimated to be valued at US$ 6.33 billion in 2021 and is expected to...